<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04737356</url>
  </required_header>
  <id_info>
    <org_study_id>SIA</org_study_id>
    <nct_id>NCT04737356</nct_id>
  </id_info>
  <brief_title>SIA - Internet-administered CBT for Adolescents With Low Self-esteem</brief_title>
  <official_title>SIA - Internet-administered CBT for Adolescents With Low Self-esteem</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Linkoeping University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Linkoeping University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will investigate a novel CBT based treatment approach for low self-esteem among&#xD;
      adolescents.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">February 15, 2021</start_date>
  <completion_date type="Anticipated">February 15, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 15, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Rosenberg Self-Esteem Scale</measure>
    <time_frame>Before treatment, after 3 weeks, after 7 weeks and follow-up at 12 months after treatment termination.</time_frame>
    <description>A 10-item measure of self-esteem. Sum scores range between 0-30. A higher score indicates a higher self-esteem.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Brunnsviken Brief Quality of Life Questionnaire</measure>
    <time_frame>Before treatment, after 7 weeks and follow-up at 12 months after treatment termination.</time_frame>
    <description>Measure of subjective quality of life. Sum scores can range between 0 and 96. Higher scores indicate a higher quality of life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Robson Self-concept Questionnaire</measure>
    <time_frame>Before treatment, after 7 weeks and follow-up at 12 months after treatment termination.</time_frame>
    <description>A 30-item measure of self-esteem. Sum scores range between 0-210. A higher score indicates a higher self-esteem.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Self-Compassion Scale Short Format</measure>
    <time_frame>Before treatment, after 7 weeks and follow-up at 12 months after treatment termination.</time_frame>
    <description>A 12-item measure of self-compassion. Sum scores range between 1-5. A higher score indicates higher self-compassion.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Performance based self-esteem Scale</measure>
    <time_frame>Before treatment, after 7 weeks and follow-up at 12 months after treatment termination.</time_frame>
    <description>A 4-item measure of performance based self-esteem. Sum scores range between 4-20. A higher score indicates a higher performance based self-esteem.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Patient Health Questionnaire</measure>
    <time_frame>Before treatment, after 7 weeks and follow-up at 12 months after treatment termination.</time_frame>
    <description>A 9 item measure of depressive symptoms. Sum scores range from 0-27. A higher score indicates more depressive symptoms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Generalised Anxiety Disorder 7-item scale</measure>
    <time_frame>Before treatment, after 7 weeks and follow-up at 12 months after treatment termination.</time_frame>
    <description>Seven item measure of generalized anxiety disorder. Sum score range from 0 to 21, with higher scores indicating more generalized anxiety. Cut-offs for interpretation: 0-5 minimal anxiety, 6-9 mild anxiety, 10-14 moderate anxiety, and 15-21 severe anxiety.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Alcohol Use Disorder Identification Test</measure>
    <time_frame>Before treatment, after 7 weeks and follow-up at 12 months after treatment termination.</time_frame>
    <description>A 10 item measure of alcohol use disorders. Sum scores range from 0-40. A higher score indicates higher alcohol use.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Rathus assertiveness schedule - 6</measure>
    <time_frame>Before treatment, after 7 weeks and follow-up at 12 months after treatment termination.</time_frame>
    <description>Six item measure of assertiveness. Sum score range from -18 to 18. A higher score indicates higher assertiveness.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Self Esteem</condition>
  <arm_group>
    <arm_group_label>Cognitive Behavior Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Therapist-Guided Internet based Cognitive Behavior Therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Wait-list control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Wait-list control participants will receive the same treatment at the end of the study period.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Cognitive behavior therapy</intervention_name>
    <description>Internet-based CBT intervention based on CBT theory as well as self-determination therapy for low self-esteem among adolescents.</description>
    <arm_group_label>Cognitive Behavior Therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Low self-esteem, as indicated by rating of &lt; 20 the Rosenberg Self-Esteem Scale.&#xD;
&#xD;
          -  Age between 15 and 19 years old.&#xD;
&#xD;
          -  Access to a computer, smartphone, or tablet with internet access.&#xD;
&#xD;
          -  Write and speak Swedish.&#xD;
&#xD;
          -  In case of use of psychotropical medication, a stable dose for the past three months&#xD;
             prior to registration and no planned changes during the treatment.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Other ongoing psychological treatment that affects the treatment received in the&#xD;
             study.&#xD;
&#xD;
          -  No comorbid severe depressive symptoms and no suicidal plans.&#xD;
&#xD;
          -  Ongoing alcohol use disorder, as indicated by Alcohol Use Disorders Identification&#xD;
             Test (AUDIT).&#xD;
&#xD;
          -  Severe psychiatric comorbidities (e.g. psychosis, anorexia nervosa) that requires&#xD;
             specialist care within the regular psychiatric care.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>19 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gerhard Andersson</last_name>
    <role>Principal Investigator</role>
    <affiliation>Linkoeping University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Linköping University</name>
      <address>
        <city>Linköping</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>January 28, 2021</study_first_submitted>
  <study_first_submitted_qc>February 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 3, 2021</study_first_posted>
  <last_update_submitted>March 15, 2021</last_update_submitted>
  <last_update_submitted_qc>March 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Linkoeping University</investigator_affiliation>
    <investigator_full_name>Gerhard Andersson</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>cognitive behavior therapy</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

